HC2 Holdings (HCHC) Says Pansend Life Sciences Portfolio Company BeneVir Biopharm to be Acquired by Janssen Biotech (JNJ) for up to $1.04 Billion
Tweet Send to a Friend
HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that BeneVir Biopharm, Inc. (“BeneVir”), a privately-held biotechnology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
